Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Locatelli

Showing results (531-540 of 665) with videos related to

Pageof 67
Sort By:
Plos Neglected Tropical Diseases|August 14, 2015
Assessment of the Impact of Potential Tetracycline Exposure on the Phenotype of Aedes aegypti OX513A: Implications for Field UseZoe Curtis, Kelly Matzen, Marco Neira Oviedo, et al.
Haematologica|December 10, 1999
Cell therapy: achievements and perspectivesC Bordignon, C Carlo-Stella, M P Colombo, et al.
Blood|February 26, 2000
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trialF Locatelli, M Zecca, R Rondelli, et al.
The New England Journal of Medicine|August 7, 1997
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation GroupE Gluckman, V Rocha, A Boyer-Chammard, et al.
Bone Marrow Transplantation|August 6, 1999
Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)P Iacopino, G Pucci, W Arcese, et al.
Leukemia|April 27, 2007
Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCRG Porta, E Maserati, E Mattarucchi, et al.
Blood|August 29, 2000
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trialF Locatelli, B Bruno, M Zecca, et al.
British Journal of Haematology|January 1, 1996
Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemiaF Locatelli, A Pession, P Comoli, et al.
International Journal of Immunogenetics|September 21, 2006
Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantationF E Bertinetto, A M Dall'Omo, G A Mazzola, et al.
Blood Cancer Journal|November 19, 2013
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemiaD Hasegawa, C Bugarin, M Giordan, et al.
Pageof 67

Showing results (531-540 of 665) with videos related to

Sort By:
Pageof 67
Plos Neglected Tropical Diseases|August 14, 2015
Assessment of the Impact of Potential Tetracycline Exposure on the Phenotype of Aedes aegypti OX513A: Implications for Field UseZoe Curtis, Kelly Matzen, Marco Neira Oviedo, et al.
Haematologica|December 10, 1999
Cell therapy: achievements and perspectivesC Bordignon, C Carlo-Stella, M P Colombo, et al.
Blood|February 26, 2000
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trialF Locatelli, M Zecca, R Rondelli, et al.
The New England Journal of Medicine|August 7, 1997
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation GroupE Gluckman, V Rocha, A Boyer-Chammard, et al.
Bone Marrow Transplantation|August 6, 1999
Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)P Iacopino, G Pucci, W Arcese, et al.
Leukemia|April 27, 2007
Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCRG Porta, E Maserati, E Mattarucchi, et al.
Blood|August 29, 2000
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trialF Locatelli, B Bruno, M Zecca, et al.
British Journal of Haematology|January 1, 1996
Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemiaF Locatelli, A Pession, P Comoli, et al.
International Journal of Immunogenetics|September 21, 2006
Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantationF E Bertinetto, A M Dall'Omo, G A Mazzola, et al.
Blood Cancer Journal|November 19, 2013
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemiaD Hasegawa, C Bugarin, M Giordan, et al.
Pageof 67